Disclosures & Course Information
Incorporating the 2025 AGA Clinical Practice Guidelines
Target Audience: Registered Nurses, GI/Endoscopy Nurses, Advanced Practice Nurses
Release Date: February 2026 | Expiration Date: February 2029
Nevada State Board of Nursing Approved CE Provider (NV-14175)
The author and planning committee members have no relevant financial relationships with ineligible companies to disclose. All content has been reviewed for bias and clinical accuracy.
This continuing education activity has received no commercial support.
This educational activity includes discussion of the following off-label or investigational uses:
Erythromycin — used off-label as a prokinetic agent at doses lower than antibiotic dosing
Domperidone — not FDA-approved in the United States; requires FDA Expanded Access IND
Prucalopride — FDA-approved for chronic idiopathic constipation; used off-label for gastroparesis
Mirtazapine — used off-label for nausea and appetite stimulation in gastroparesis